Designing Peptide Vaccines to Broaden Recognition and Enhance Potency
- 1 May 1995
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 754 (1 Combined), 161-168
- https://doi.org/10.1111/j.1749-6632.1995.tb44449.x
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Sequence features that correlate with MHC restrictionMolecular Immunology, 1994
- Toward a Vaccine for AIDS: The Emergence of Immunobiology-Based Vaccine DevelopmentAnnual Review of Immunology, 1994
- Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 moleculesCell, 1993
- Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1Nature, 1993
- Identification of peptide sequences that potentially trigger HLA‐A2.1‐restricted cytotoxic T lymphocytesEuropean Journal of Immunology, 1993
- The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHCCell, 1992
- Crystal Structures of Two Viral Peptides in Complex with Murine MHC Class I H-2K bScience, 1992
- Characterization of Peptides Bound to the Class I MHC Molecule HLA-A2.1 by Mass SpectrometryScience, 1992
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991
- T cell multideterminant regions in the human immunodeficiency virus envelope: toward overcoming the problem of major histocompatibility complex restrictionInternational Immunology, 1989